Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1176-1184, June 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rauscher, F. J.
Right arrow Articles by Baker, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rauscher, F. J., Jr.
Right arrow Articles by Baker, C. G.

Survey of Viral Oncology with Particular Reference to Lymphomas

Frank J. Rauscher, Jr., Louis M. Carrese and Carl G. Baker

National Cancer Institute, NIH, Bethesda, Maryland

Selected facts and leads recently reported from viral studies in animal and human leukemias and lymphomas are described and are discussed within the scientific framework of the Special Virus-Leukemia Program of the National Cancer Institute. Data from investigations with murine and avian leukemias, human acute leukemia, and in particular with Burkitt lymphoma patients and materials are presented which contribute to a conviction that sufficient knowledge, information, and technical capability now exist to plan and implement an intensified program, the main objectives of which are (a) to determine whether viruses comparable to those now known to be associated with avian and murine leukemia are etiologic agents of human leukemia, and (b) to develop an effective vaccine or other means for the prevention and/or control of human leukemia and lymphoma if such etiologic agents are found. The underlying program assumption—that at least 1 virus is an indispensable element for the induction (directly or indirectly) of at least 1 kind of human leukemia (including lymphoma) and that the virus persists in the diseased individual—is discussed in relation to apparent similarities between human leukemia and virus-induced animal leukemia.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.